72817-94-8

Basic information

• Product Name: Benzoic acid, 4-amino-5-cyano-2-hydroxy-3-methyl- (9CI)
• Synonyms: Benzoic acid, 4-amino-5-cyano-2-hydroxy-3-methyl- (9CI);Benzoic acid, 4-aMino-5-cyano-2-hydroxy-3-Methyl-;4-Amino-5-cyano-2-hydroxy-3-methylbenzoic acid
• CAS NO: 72817-94-8
• Molecular Formula: C₉H₈N₂O₃
• Molecular Weight: 192.17142
• Product Categories: AMINOACID
• Mol File: 72817-94-8.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: Benzoic acid, 4-amino-5-cyano-2-hydroxy-3-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-amino-5-cyano-2-hydroxy-3-methyl- (9CI)(72817-94-8)
• EPA Substance Registry System: Benzoic acid, 4-amino-5-cyano-2-hydroxy-3-methyl- (9CI)(72817-94-8)

Safety Data

• Hazardous Substances Data: 72817-94-8(Hazardous Substances Data)

Upstream product

• 72817-85-7 4-Amino-5-cyan-3-methyl-salicylsaeure-ethylester 

Downstream Products

• 102569-26-6 2-amino-4-hydroxy-3-methylbenzonitrile 
• 102569-32-4 2-Amino-5-bromo-4-hydroxy-3-methyl-benzonitrile 
• 922520-33-0 2-amino-4-methoxy-3-methyl benzamide 
• 922520-32-9 2-amino-4-methoxy-3-methyl-benzoic acid methyl ester 
• 922520-29-4 7-Methoxy-8-methyl-2-phenylquinazolin-4-ol 
• 1202186-95-5 C₁₅H₁₅N₃O₃ 
• 922520-24-9 2-(4-fluoro-phenyl)-7-methoxy-8-methyl-quinazolin-4-ol 
• 922520-23-8 2-(4-fluoro-benzoylamino)-4-methoxy-3-methyl-benzoic acid 
• 922520-22-7 2-(4-fluoro-benzoylamino)-4-methoxy-3-methyl-benzoic acid methyl ester 
• 923274-68-4 2-amino-4-methoxy-3-methylbenzonitrile 
• 923275-56-3 2-amino-4-methoxy-3-methyl benzoic acid 
• 923275-17-6 2-chloro-4-hydroxy-7-methoxy-8-methylquinazoline 
• 923274-98-0 4-Methoxy-3-methyl-2-[(5-methyl-pyridine-2-carbonyl)-amino]-benzoic acid methyl ester 
• 923274-69-5 4-Isopropylthiazole-2-carboxylic acid (6-carbamoyl-3-methoxy-2-methyl-phenyl)-amide 

Relevant articles and documents

Macrocylic Inhibitors of Hepatitis C Virus

Compounds of the formula I: and N-oxides, salts, and stereoisomers thereof wherein A is OR1, NHS(═O)pR2; wherein; R1 is hydrogen, C1-C6alkyl, C0-C3alkylenecarbocyclyl, C0-C3alkylene-heterocyclyl;R2 is C1-C6alkyl, C0-C3alkylenecarbocyclyl, C0-C3alkyleneheterocyclyl;p is independently 1 or 2;n is 3, 4, 5 or 6; — denotes an optional double bond;L is N or CRz; Rz is H or forms a double bond with the asterisked carbon;Rq is H or when L is CRz, Rq can also be C1-C6alkyl;Rr is quinazolinyl, optionally substituted with one two or three substituents each independently selected from C1-C6 alkyl, C1-C6alkoxy, hydroxyl, halo, haloC1-C6alkyl, amino, mono- or dialkylamino, mono- or dialkylaminocarbonyl, C1-C6alkyl-carbonylamino, C0-C3alkylenecarbocyclyl and C0-C3 alkyleneheterocyclyl;R5 is hydrogen, C1-C6alkyl, C1-C6alkoxyC1-C6alkyl or C3-C7cycloalkyl;R6 is hydrogen, C1-C6alkyl, C1-C6alkoxy, C0-C3alkylenecarbocyclyl, C0-C3alkylene-heterocyclyl, hydroxy, bromo, chloro or fluoro have utility in the treatment or prophylaxis of flaviviral infections such as HCV